Creating Pathways to Innovation
Create a dynamic market for biomedical innovation by advancing new and innovative business, research, transaction, and financing models.
We Do This By
Elevating patient voices to generate momentum around the development of payment models that will make these treatments accessible to patients.
Continue to advance thinking and practice around the role of venture philanthropy as a distinctive source of capital for medical R&D.
Creating Markets for Medical Innovation with Lower Commercial Potential
Over the past decade, pressure from insurers and regulators has forced greater attention to how capital is allocated and has created strong incentives for specialization among the established players. One unfortunate result: cuts in the pipeline for the development of new therapeutic compounds.